tiprankstipranks
Advertisement
Advertisement
Supernus enters into asset purchase agreement with Navitor
PremiumThe FlySupernus enters into asset purchase agreement with Navitor
2M ago
Supernus Pharmaceuticals Braces for 2025 U.S. Drug Pricing Orders and MFN Rules That Threaten Revenues and Global Expansion
Premium
Company Announcements
Supernus Pharmaceuticals Braces for 2025 U.S. Drug Pricing Orders and MFN Rules That Threaten Revenues and Global Expansion
3M ago
Supernus Pharmaceuticals Balances Record Sales With Rising Costs
Premium
Company Announcements
Supernus Pharmaceuticals Balances Record Sales With Rising Costs
3M ago
Supernus reports Q4 EPS (7c) vs 27c last year
PremiumThe FlySupernus reports Q4 EPS (7c) vs 27c last year
3M ago
Supernus sees FY26 revenue $840M-$870M, consensus $861.24M
Premium
The Fly
Supernus sees FY26 revenue $840M-$870M, consensus $861.24M
3M ago
Is SUPN a Buy, Before Earnings?
Premium
Pre-Earnings
Is SUPN a Buy, Before Earnings?
3M ago
Supernus Pharmaceuticals: Strategic Growth, Clinical Advances, and Strong Financial Synergies Drive Buy Rating
PremiumRatingsSupernus Pharmaceuticals: Strategic Growth, Clinical Advances, and Strong Financial Synergies Drive Buy Rating
5M ago
Supernus management to meet virtually with Cantor Fitzgerald
Premium
The Fly
Supernus management to meet virtually with Cantor Fitzgerald
5M ago
Bank of America Highlights Five Stocks It Says Still Offer Clear Upside in 2025
Premium
Market News
Bank of America Highlights Five Stocks It Says Still Offer Clear Upside in 2025
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100